Cargando…
Potential Utility of Sodium Selenate as an Adjunct to Metformin in Treating Type II Diabetes Mellitus in Rats: A Perspective on Protein Tyrosine Phosphatase
Metformin is widely regarded as the standard first-line antidiabetic agent, in terms of efficacy and safety profiles. However, in most patients with type II diabetes mellitus (T2DM), it was found that metformin alone is not enough to adequately control hyperglycemia. Thus, we designed this study wit...
Autores principales: | Salama, Rania M., Schaalan, Mona F., Elkoussi, Alaaeldin A., Khalifa, Amani E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784083/ https://www.ncbi.nlm.nih.gov/pubmed/24106697 http://dx.doi.org/10.1155/2013/231378 |
Ejemplares similares
-
Safety and efficacy of sodium selenate as feed additive for ruminants
por: Bampidis, Vasileios, et al.
Publicado: (2019) -
Sodium selenate as a therapeutic for tauopathies: A hypothesis paper
por: Dilcher, Roxane, et al.
Publicado: (2022) -
Comparison of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus
por: Ziaee, Amir, et al.
Publicado: (2017) -
Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer’s disease
por: Zheng, Lin, et al.
Publicado: (2016) -
Rice seed priming with sodium selenate: Effects on germination, seedling growth, and biochemical attributes
por: Du, Bin, et al.
Publicado: (2019)